- The trend backdrop is active with a 9-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
GPTHEALTH
NSI
Week ended 07 Aug 2026
Weekly Investor Report
GPT Healthcare Limited · Healthcare · Medical Care Facilities
Latest close
159.4 INR
-6.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 14.4% above the Trend Line and sits at 74.1% of its 52-week range. The latest completed week returned -6.5%, after a 1.8% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100.
Setup score
64
out of 100
Latest Close
159.4 INR
7 Aug 2026
1W Return
-6.5%
latest completed week
4W Return
1.8%
short-term follow-through
12W Return
12.6%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
2.8x
vs 13-week average
- Next-week expectancy is negative at 42.36% based on similar historical setup states.
- The latest week was a sharp negative move.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.5%
Latest completed week; four-week move 1.8%.
Indicator stack
46/70
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 42.36%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
52/100
40 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 14.4% above the Trend Line and sits at 74.1% of its 52-week range. The latest completed week returned -6.5%, after a 1.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8812-week average 0.53
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.8% over four weeks, 12.6% over 12 weeks, and 1.4% over one year. The current trend has remained active for 9 consecutive weeks.
Performance by holding period
Active trend streak9 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.14Latest activity-pressure read.
Pressure change-0.8%Four-week change in activity pressure.
Leadership12.92Latest relative-leadership reading.
RS change3.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 88%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength75/100Blend of value, momentum, and quality. Underlying universe rank 26; rank 1 is best.
Value41/100Relative valuation strength. Underlying universe rank 60; rank 1 is best.
Quality94/100Profitability and accounting quality. Underlying universe rank 7; rank 1 is best.
Momentum65/100Medium-term price momentum. Underlying universe rank 36; rank 1 is best.
Growth32/100Revenue and earnings growth. Underlying universe rank 69; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework48/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 31.0x Price divided by trailing earnings.
- Price / sales
- 2.8x Market value relative to trailing revenue.
- EV / EBITDA
- 15.5x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 2.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 63.1% Gross profit retained from each unit of revenue.
- Operating margin
- 12.1% Operating profit retained from revenue.
- Free-cash-flow margin
- 8.3% Free cash flow generated from revenue.
- Return on invested capital
- 12.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 16.5% Latest one-year revenue growth.
- EPS growth
- -15.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 125.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.6% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 1.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment52/100
Weighted news tone is neutral across 40 relevant articles.
6 positive · 32 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.9%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+13.5%Week of 10 Apr.
Worst week-6.5%Week of 7 Aug.
Latest week-6.5%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains2
Flat weeks0
Modest losses16
Sharp losses1
Recent vol4.1%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -1.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank- / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank10 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape62/100
Trend, activity pressure, participation, and risk combine to a 62/100 tape read.
Indicator analysis83/100Latest 12-week confirmation: trend 9/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.88; No reversal markers Next-Week ExpectancyNegative 42.36%Next-week expectancy is negative with a 42.36% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors69/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 33; Small Cap Core rank 47 SVQF48/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 824.5 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment52/100Weighted news tone is neutral across 40 relevant articles.
Why Is Pfizer (NYSE:PFE) Takes Center Stage Amid Healthcare Earnings and M&A? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 159.4 INR | -6.5% | 139.3 INR | 154.1 INR | 1.14 | 12.92 | 1.7M | On |
| 31 Jul 2026 | 170.5 INR | 7.8% | 138.5 INR | 154.1 INR | 1.22 | 21.69 | 1.9M | On |
| 24 Jul 2026 | 158.2 INR | 4.7% | 137.5 INR | 154.0 INR | 1.19 | 15.75 | 942.8K | On |
| 17 Jul 2026 | 151.2 INR | -3.5% | 136.8 INR | 153.9 INR | 1.09 | 8.13 | 305.3K | On |
| 10 Jul 2026 | 156.7 INR | -0.4% | 136.3 INR | 153.9 INR | 1.14 | 12.50 | 704.6K | On |
| 3 Jul 2026 | 157.4 INR | 7.7% | 135.8 INR | 153.9 INR | 1.03 | 12.56 | 452.0K | On |
| 26 Jun 2026 | 146.2 INR | -1.1% | 135.3 INR | 153.9 INR | 0.95 | 5.66 | 0 | On |
| 19 Jun 2026 | 147.8 INR | -0.2% | 135.1 INR | 154.0 INR | 0.96 | 7.19 | 88.6K | On |
| 12 Jun 2026 | 148.2 INR | -1.0% | 135.0 INR | 154.0 INR | 0.96 | 9.40 | 55.2K | On |
| 5 Jun 2026 | 149.6 INR | 5.1% | 134.8 INR | 154.1 INR | 0.99 | 11.81 | 128.7K | Off |
| 29 May 2026 | 142.4 INR | 1.7% | 134.7 INR | 154.1 INR | 1.05 | 5.76 | 407.8K | Off |
| 22 May 2026 | 140.0 INR | -1.1% | 134.9 INR | 154.2 INR | 1.07 | 3.22 | 503.4K | Off |
| 15 May 2026 | 141.6 INR | -1.8% | 135.2 INR | 154.3 INR | 1.06 | 4.61 | 507.0K | Off |
| 8 May 2026 | 144.1 INR | 4.1% | 135.3 INR | 154.4 INR | 1.04 | 4.06 | 895.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.